Filing Details

Accession Number:
0000914062-13-000255
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-04 17:14:18
Reporting Period:
2013-11-01
Filing Date:
2013-11-04
Accepted Time:
2013-11-04 17:14:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1522480 F John Mauldin C/O Galectin Therapeutics Inc.
4960 Peachtree Industrial Blvd, Ste 240
Norcross GA 30071
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-01 478 $10.43 16,847 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,947 Indirect By Trust
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2013.
  2. Reflects weighted average price. Range of prices were between $10.41 and 10.45. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.